DK0741744T3 - Immunogener mod gonadeotropinfrigørende hormon - Google Patents
Immunogener mod gonadeotropinfrigørende hormonInfo
- Publication number
- DK0741744T3 DK0741744T3 DK95909395T DK95909395T DK0741744T3 DK 0741744 T3 DK0741744 T3 DK 0741744T3 DK 95909395 T DK95909395 T DK 95909395T DK 95909395 T DK95909395 T DK 95909395T DK 0741744 T3 DK0741744 T3 DK 0741744T3
- Authority
- DK
- Denmark
- Prior art keywords
- gonadeotropin
- releasing hormone
- immunogens against
- immunogenic compositions
- mammals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
- Y10S530/852—Sperm
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
- Y10S530/852—Sperm
- Y10S530/853—Ovary; eggs; embryos
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/854—Glands
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/11—Gonadotropin; related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/13—Luteinizing hormone-releasing hormone; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/188,223 US5688506A (en) | 1994-01-27 | 1994-01-27 | Immunogens against gonadotropin releasing hormone |
PCT/US1995/001225 WO1995020600A1 (fr) | 1994-01-27 | 1995-01-26 | Immunogenes contre l'hormone liberant la gonadotrophine |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0741744T3 true DK0741744T3 (da) | 1999-12-06 |
Family
ID=22692254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95909395T DK0741744T3 (da) | 1994-01-27 | 1995-01-26 | Immunogener mod gonadeotropinfrigørende hormon |
Country Status (10)
Country | Link |
---|---|
US (3) | US5688506A (fr) |
EP (1) | EP0741744B1 (fr) |
JP (1) | JP3477713B2 (fr) |
AT (1) | ATE183198T1 (fr) |
AU (1) | AU698738B2 (fr) |
DE (1) | DE69511379T2 (fr) |
DK (1) | DK0741744T3 (fr) |
ES (1) | ES2137498T3 (fr) |
GR (1) | GR3031716T3 (fr) |
WO (1) | WO1995020600A1 (fr) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6030617A (en) * | 1993-01-12 | 2000-02-29 | The Johns Hopkins University School Of Medicine | Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
US5688506A (en) * | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
GB9514816D0 (en) | 1995-07-19 | 1995-09-20 | Ucli Ltd | Substances and their medical use |
EP0889735B1 (fr) * | 1996-02-08 | 2011-04-13 | Cancer Advances, Inc., | Procedes immunologiques appliques dans le traitement du cancer du tube digestif |
US20040001842A1 (en) * | 1997-05-12 | 2004-01-01 | Dov Michaeli | Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors |
CA2287872C (fr) * | 1997-05-12 | 2010-07-27 | Aphton Corporation | Compositions immunogenes dirigees contre le recepteur de cck-b/gastrine et procede de traitement des tumeurs |
AUPO776897A0 (en) * | 1997-07-09 | 1997-07-31 | Csl Limited | A method of achieving production gains in livestock and agents useful for same |
JP2002515458A (ja) * | 1998-05-15 | 2002-05-28 | アフトン・コーポレーシヨン | 高ガストリン血症の予防および処置 |
US20030068326A1 (en) * | 1998-05-15 | 2003-04-10 | Aphton Corporation | Method for the treatment of gastroesophageal reflux disease |
AUPP807399A0 (en) | 1999-01-08 | 1999-02-04 | Csl Limited | Improved immunogenic lhrh composition and methods relating thereto |
GB9924351D0 (en) * | 1999-10-14 | 1999-12-15 | Brennan Frank | Immunomodulation methods and compositions |
AU770475B2 (en) * | 1999-12-23 | 2004-02-19 | Aphton Corporation | A stable immunogenic composition for frozen storage |
WO2001085763A2 (fr) * | 2000-05-05 | 2001-11-15 | Aphton Corporation | Peptides chimeres a efficacite immunogene |
ES2377077T3 (es) | 2000-10-18 | 2012-03-22 | Glaxosmithkline Biologicals S.A. | Vacunas que comprenden al antígeno MAGE unido a un fragmento de proteína D |
AU2002246758A1 (en) | 2000-12-29 | 2002-07-16 | Vanderbilt University | Epididymal lipocalin gene and uses thereof |
US20030091574A1 (en) | 2001-03-23 | 2003-05-15 | Gevas Philip C. | Combination treatment of pancreatic cancer |
US20090191232A1 (en) | 2001-05-04 | 2009-07-30 | Gevas Philip C | Combination therapy for the treatment of tumors |
US6810583B2 (en) * | 2001-08-07 | 2004-11-02 | International Business Machines Corporation | Coupling of conductive vias to complex power-signal substructures |
IL147138A0 (en) * | 2001-12-17 | 2002-08-14 | Yeda Res & Dev | Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation |
JP2005535663A (ja) * | 2002-07-03 | 2005-11-24 | アフトン コーポレーション | リポソームワクチン |
US20040247661A1 (en) * | 2002-07-03 | 2004-12-09 | Dov Michaeli | Liposomal vaccine |
US20050169979A1 (en) * | 2002-07-03 | 2005-08-04 | Dov Michaeli | Liposomal vaccine |
US7235376B2 (en) * | 2003-03-28 | 2007-06-26 | Receptor Biologix, Inc. | Gastrin hormone immunoassays |
PT1684782E (pt) | 2003-10-03 | 2015-12-21 | Thorn Bioscience Llc | Processo para a sincronização da ovulação para reprodução regulada sem detecção do cio |
DE602005012097D1 (de) | 2004-04-26 | 2009-02-12 | Innate Pharma | Adjuvante zusammensetzung und anwendungsverfahren dafür |
WO2005120552A1 (fr) * | 2004-06-11 | 2005-12-22 | Ym Biosciences Inc. | Procedes et formulations de chimeres de gnrh/leucotoxine en vue de la suppression de testosterone |
ES2400058T3 (es) | 2004-09-22 | 2013-04-05 | Cancer Advances, Inc. | Anticuerpos monoclonales para progastrina |
TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
EP2010569A4 (fr) | 2006-03-20 | 2009-09-09 | Xoma Technology Ltd | Anticorps humains spécifiques à des matières et des procédés à base de gastrines |
US8143426B2 (en) * | 2006-07-24 | 2012-03-27 | Tetralogic Pharmaceuticals Corporation | IAP inhibitors |
US20090181078A1 (en) | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
SI2068918T1 (sl) | 2006-09-26 | 2012-09-28 | Infectious Disease Res Inst | Si - ep sestavek za cepljenje, ki vsebuje sintetiäśna pomagala |
EP2086582B1 (fr) | 2006-10-12 | 2012-11-14 | GlaxoSmithKline Biologicals s.a. | Vaccin comprenant une emulsion adjuvante huile en l'eau |
US20100183667A1 (en) | 2006-10-12 | 2010-07-22 | Glaxo Smithkline Biologicals S.A. | Vaccine Comprising an Oil in Water Emulsion Adjuvant |
EP2148697B1 (fr) | 2007-05-24 | 2012-10-03 | GlaxoSmithKline Biologicals S.A. | Composition lyophilisée contenant wt-1 et cpg |
EP2072060A1 (fr) | 2007-12-18 | 2009-06-24 | Institut Curie | Procédés et compositions pour la préparation et l'utilisation de conjugués de toxines |
CA2739318A1 (fr) | 2008-08-07 | 2010-02-11 | Mercia Pharma, Llc | Compositions immunotherapeutiques pour le traitement de la maladie d'alzheimer |
CU23739A1 (es) | 2008-09-30 | 2011-12-28 | Ct Ingenieria Genetica Biotech | Composición farmacéutica utilizando combinaciones de variantes de la hormona liberadora de las gonadotropinas (gnrh) como inmunógeno |
ES2661240T3 (es) | 2009-04-23 | 2018-03-28 | Jbs United Animal Health Ii Llc | Método y composición para sincronizar el momento de inseminación |
RU2732574C2 (ru) | 2009-06-05 | 2020-09-21 | Инфекшес Дизиз Рисерч Инститьют | Синтетические глюкопиранозиллипидные адъюванты |
US8283372B2 (en) | 2009-07-02 | 2012-10-09 | Tetralogic Pharmaceuticals Corp. | 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic |
CA2826920A1 (fr) | 2011-02-15 | 2012-08-23 | Immune Design Corp. | Procedes d'amelioration des reponses immunitaires specifiques d'un immunogene avec des vaccins vectorises |
CA2832307A1 (fr) | 2011-04-08 | 2012-10-18 | Immune Design Corp. | Compositions immunogenes et leurs procedes d'utilisation pour induire des reponses immunitaires humorales et cellulaires |
GB201121571D0 (en) | 2011-12-15 | 2012-01-25 | Astrimmune Ltd | Compounds and uses thereof |
CN110339160A (zh) | 2012-02-07 | 2019-10-18 | 传染性疾病研究院 | 包含tlr4激动剂的改进佐剂制剂及其使用方法 |
NZ701881A (en) | 2012-05-16 | 2016-10-28 | Immune Design Corp | Vaccines for hsv-2 |
WO2014052693A2 (fr) | 2012-09-29 | 2014-04-03 | The Trustees Of The University Of Pennsylvania | Composition à usage vétérinaire et procédés de stérilisation et de castration non chirurgicaux |
US9724380B2 (en) | 2012-11-28 | 2017-08-08 | Jbs United Animal Health Ii Llc | Method and compositions for synchronizing time of insemination in gilts |
AU2014253791B2 (en) | 2013-04-18 | 2019-05-02 | Immune Design Corp. | GLA monotherapy for use in cancer treatment |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
EA201691348A1 (ru) | 2013-12-31 | 2016-11-30 | Инфекшес Дизиз Рисерч Инститьют | Однофлаконные вакцинные составы |
MX2017000630A (es) | 2014-07-15 | 2017-04-27 | Immune Design Corp | Regimenes de sensibilización-refuerzo con un adyuvante de agonista tlr4 y un vector lentiviral. |
EP3443123B1 (fr) | 2016-04-11 | 2021-08-11 | Board of Regents, The University of Texas System | Procédés et compositions pour détecter la séquence et l'affinité vis-à-vis d'un récepteur unique de lymphocyte t |
ES2929054T3 (es) | 2016-05-16 | 2022-11-24 | Access To Advanced Health Inst | Formulación que contiene un agonista de TLR y métodos de uso |
MX2018013640A (es) | 2016-05-16 | 2019-08-01 | Infectious Disease Res Inst | Liposomas pegiladas y metodos de uso. |
KR20220165789A (ko) | 2016-06-01 | 2022-12-15 | 액세스 투 어드밴스드 헬스 인스티튜트 | 사이징제를 함유하는 나노명반 입자 |
EP3624841A4 (fr) | 2017-06-15 | 2021-01-27 | Cancer Advances, Inc., | Compositions et procédés pour induire des immunités humorales et cellulaires contre des tumeurs et un cancer |
MX2019015076A (es) | 2017-06-15 | 2020-08-03 | Infectious Disease Res Inst | Portadores lípidos nanoestructurados y emulsiones estables y usos de los mismos. |
AU2018330165A1 (en) | 2017-09-08 | 2020-04-02 | Access To Advanced Health Institute | Liposomal formulations comprising saponin and methods of use |
EP3976092A1 (fr) | 2019-05-25 | 2022-04-06 | Infectious Disease Research Institute | Composition et procédé de séchage par atomisation d'une émulsion de vaccin et d'adjuvant |
US20230310569A1 (en) | 2020-09-04 | 2023-10-05 | Access To Advanced Health Institute | Genetically-adjuvanted rna vaccines |
US20230310323A1 (en) | 2020-09-04 | 2023-10-05 | Access To Advanced Health Institute | Co-lyophilized rna and nanostructured lipid carrier |
CA3173408A1 (fr) | 2020-12-23 | 2022-06-30 | Access To Advanced Health Institute | Adjuvants de vaccins a base de solanesol et leurs procedes de preparation |
WO2024052882A1 (fr) | 2022-09-09 | 2024-03-14 | Access To Advanced Health Institute | Composition de vaccin immunogène incorporant une saponine |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4384995A (en) * | 1980-01-16 | 1983-05-24 | The Ohio State University | Antigenic modification of polypeptides |
US4302386A (en) * | 1978-08-25 | 1981-11-24 | The Ohio State University | Antigenic modification of polypeptides |
US4526716A (en) * | 1981-11-20 | 1985-07-02 | The Ohio State University | Antigenic modification of polypeptides |
US4201770A (en) * | 1973-05-07 | 1980-05-06 | The Ohio State University | Antigenic modification of polypeptides |
US4691006A (en) * | 1983-03-04 | 1987-09-01 | Ohio State University | Antigenic modification of polypeptides |
US3963691A (en) * | 1974-10-07 | 1976-06-15 | Merck & Co., Inc. | Synthetic antigens of luteinizing hormone releasing hormone |
US4618598A (en) * | 1982-04-12 | 1986-10-21 | Duke University | Method of regulating hormone function or release |
US4676981A (en) * | 1984-02-07 | 1987-06-30 | University Of Saskatchewan | Monoclonal antibodies against GnRH |
US4879112A (en) * | 1984-02-07 | 1989-11-07 | University Of Saskatchewan | Monoclonal antibodies agaisnt GnRH |
US4608251A (en) * | 1984-11-09 | 1986-08-26 | Pitman-Moore, Inc. | LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues |
WO1986004243A1 (fr) * | 1985-01-25 | 1986-07-31 | The Population Council, Inc. | Procede et produit ameliorant la reaction d'un anticorps en circulation |
US4740500A (en) * | 1985-01-31 | 1988-04-26 | The Salk Institute For Biological Studies | GnRH antagonists VIII |
IL78775A (en) * | 1985-05-15 | 1992-06-21 | Biotech Australia Pty Ltd | Oral vaccines |
EP0224574A4 (fr) * | 1985-06-04 | 1988-04-26 | Biotech Res Partners Ltd | Vaccins auto-antigenes. |
CA1239346A (fr) * | 1985-06-04 | 1988-07-19 | Gursaran P. Talwar | Vaccin anticonceptionnel |
FR2593705B1 (fr) | 1986-02-04 | 1991-07-26 | Lafon Labor | Composition pour l'interruption de la grossesse comprenant des anticorps monoclonaux reconnaissant l'hormone chorionique gonadotrope ou un peptide de structure analogue, anticorps monoclonaux, procede de production de ces anticorps, hybridomes et procede d'obtention de ces hybridomes |
US4795634A (en) * | 1986-03-14 | 1989-01-03 | Aphton Corporation | Method for contraception by immunization against the zona pellucida |
NZ220932A (en) * | 1986-07-03 | 1990-05-28 | Victoria State | Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying |
NZ221306A (en) * | 1986-08-15 | 1990-02-26 | Commw Scient Ind Res Org | 2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof |
GB8713240D0 (en) * | 1987-06-05 | 1987-07-08 | Proteus Biotech Ltd | Hormones |
US4975420A (en) * | 1987-09-30 | 1990-12-04 | University Of Saskatchewan | Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals |
GB8723846D0 (en) * | 1987-10-10 | 1987-11-11 | Danbiosyst Ltd | Bioadhesive microsphere drug delivery system |
FR2623715B1 (fr) | 1987-11-26 | 1990-12-21 | Lafon Labor | Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite |
IL91462A0 (en) * | 1988-08-30 | 1990-04-29 | Applied Research Systems | Recombinant fusion proteins and dna encoding for such a protein |
US5036047A (en) | 1988-09-29 | 1991-07-30 | Pitman-Moore, Inc. | Method and composition for preventing conception |
US5661126A (en) * | 1989-01-19 | 1997-08-26 | The General Hospital Corporation | Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression |
US5023077A (en) * | 1989-01-24 | 1991-06-11 | Aphton Corporation | Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease |
DE69014137T2 (de) * | 1989-01-24 | 1995-06-08 | Aphton Corp., Woodland, Calif. | Immunogenische Zusammensetzungen gegen Gastrin-Peptide. |
GB2228262B (en) * | 1989-01-25 | 1992-10-07 | Nat Inst Immunology | Antigenic derivative of gnrh |
WO1990009799A1 (fr) * | 1989-02-23 | 1990-09-07 | Colorado State University Research Foundation | ANALOGUES DE GnRH DETRUISANT LES GONADOTROPES |
US5484592A (en) * | 1989-03-23 | 1996-01-16 | Stitching Centraal Diergeneeskundig Instituut | Peptide, immunogenic composition and vaccine or medicinal preparation: a method of immunising a mammal against LHRH, and a method of improving the meat quality of pigs |
EP0446313B1 (fr) * | 1989-08-25 | 1996-07-31 | Biotechnology Australia Pty. Ltd. | Proteines de fusion comprenant TraTp et au moins un analogue de LHRH |
GB8921470D0 (en) * | 1989-09-22 | 1989-11-08 | Peptide Technology Ltd | Vaccines |
DE4003944A1 (de) | 1990-02-14 | 1991-08-22 | Gerhard Dr Prinzhaus | Synthetisches polypeptid: lh - rh -- klh (konjugat aus luteinisierendem hormon-releasing hormon und dem keyhole limpet haemocyanin |
FR2661180B1 (fr) | 1990-04-23 | 1995-04-28 | Inst Nat Sante Rech Med | (hydroxyproline 9) lhrh, son procede d'obtention et application comme medicament. |
US5648340A (en) * | 1991-10-31 | 1997-07-15 | Barnea; Eytan R. | Gestational agents for controlling cell proliferation |
US5324512A (en) * | 1990-12-26 | 1994-06-28 | The Population Council | [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses |
GB9100468D0 (en) * | 1991-01-09 | 1991-02-20 | Proteus Molecular Design | Improvements in and relating to hormones |
NL9100151A (nl) * | 1991-01-29 | 1992-08-17 | Instituut Voor Veeteeltkundig | Werkwijze voor het volledig c.q. nagenoeg volledig elimineren van de "beregeur" van vlees van opgefokte mannelijke varkens door tijdens het opfokken de mannelijke varkens te immuniseren tegen het gnrh-hormoon. |
DK0501882T3 (da) * | 1991-03-01 | 2000-12-11 | Merial Sas | Fremgangsmåde til anti-LHRH immunoneutralisering af ikke-kastrerede husdyrhanner og peptider dertil |
AU634379B2 (en) * | 1991-04-29 | 1993-02-18 | Csl Limited | Recombinant immunocastration vaccine |
US5262521A (en) * | 1991-06-07 | 1993-11-16 | Sri International | Isolated atrial peptide-degrading enzyme and novel compounds useful as inhibitors thereof |
WO1993003058A2 (fr) * | 1991-07-01 | 1993-02-18 | University Technologies International Inc. | Analogues non desensibilisants de gonadoliberine et d'autres ligands biologiquement actifs |
EP0596959B1 (fr) * | 1991-07-26 | 2000-03-29 | Commonwealth Scientific And Industrial Research Organisation | Systeme d'administration de vaccin peptidique produisant son propre adjuvant et production du vaccin |
US5723129A (en) | 1991-10-16 | 1998-03-03 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
US5837268A (en) | 1991-10-16 | 1998-11-17 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
US5422110A (en) | 1991-10-16 | 1995-06-06 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
AU2699192A (en) | 1991-10-16 | 1993-05-21 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
GB9207731D0 (en) * | 1992-04-07 | 1992-05-27 | Proteus Molecular Design | Improvements in or relating to vaccines |
ZA934199B (en) * | 1992-06-18 | 1994-01-10 | Akzo Nv | Carrier system against gnrh |
WO1994000590A1 (fr) * | 1992-06-23 | 1994-01-06 | The Mt. Sinai School Of Medicine Of The City University Of New York | CLONAGE ET EXPRESSION D'UN RECEPTEUR D'HORMONE LIBERANT DE LA GONADOTROPINE (R-HLGn) |
US5557033A (en) * | 1992-09-22 | 1996-09-17 | Regents Of The University Of Minnesota | Method of increasing egg production in avian species by active immunization against vasoactive intestinal peptide |
FR2700855B1 (fr) * | 1993-01-28 | 1995-03-03 | Commissariat Energie Atomique | Dosage immunométrique d'un antigène ou d'un haptène. |
US5759551A (en) | 1993-04-27 | 1998-06-02 | United Biomedical, Inc. | Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines |
DK0708656T3 (da) * | 1993-04-27 | 2002-12-02 | United Biomedical Inc | Antigene LHRH peptidkonstruktioner og universelle syntetiske immunstimulatorer til vacciner |
US5413990A (en) * | 1993-08-06 | 1995-05-09 | Tap Pharmaceuticals Inc. | N-terminus modified analogs of LHRH |
US5468494A (en) * | 1993-11-12 | 1995-11-21 | Aphton Corp. | Immunogenic compositions against human gastrin 17 |
US5688506A (en) * | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
US5508383A (en) * | 1994-03-09 | 1996-04-16 | Tap Holdings Inc. | Cyclic peptide LHRH antagonists |
US5506207A (en) * | 1994-03-18 | 1996-04-09 | The Salk Institute For Biological Studies | GNRH antagonists XIII |
CA2163325A1 (fr) * | 1994-11-21 | 1996-05-22 | Kaneyoshi Kato | Composes amines; preparation et utilisation |
WO1997015316A1 (fr) * | 1995-10-27 | 1997-05-01 | Merck & Co., Inc. | Conjugues de gonadoliberine |
WO1997015325A1 (fr) * | 1995-10-27 | 1997-05-01 | Merck & Co., Inc. | L'exotoxine de pseudomonas: un vecteur immunogene pour vaccins de synthese conjugues |
-
1994
- 1994-01-27 US US08/188,223 patent/US5688506A/en not_active Expired - Fee Related
-
1995
- 1995-01-26 WO PCT/US1995/001225 patent/WO1995020600A1/fr active Search and Examination
- 1995-01-26 EP EP95909395A patent/EP0741744B1/fr not_active Expired - Lifetime
- 1995-01-26 DE DE69511379T patent/DE69511379T2/de not_active Expired - Fee Related
- 1995-01-26 AT AT95909395T patent/ATE183198T1/de not_active IP Right Cessation
- 1995-01-26 ES ES95909395T patent/ES2137498T3/es not_active Expired - Lifetime
- 1995-01-26 DK DK95909395T patent/DK0741744T3/da active
- 1995-01-26 AU AU17371/95A patent/AU698738B2/en not_active Ceased
- 1995-01-26 JP JP52023395A patent/JP3477713B2/ja not_active Expired - Fee Related
- 1995-06-07 US US08/478,546 patent/US6303123B1/en not_active Expired - Fee Related
-
1997
- 1997-11-17 US US08/968,466 patent/US6132720A/en not_active Expired - Fee Related
-
1999
- 1999-11-03 GR GR990402808T patent/GR3031716T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2137498T3 (es) | 1999-12-16 |
US6132720A (en) | 2000-10-17 |
US6303123B1 (en) | 2001-10-16 |
ATE183198T1 (de) | 1999-08-15 |
JPH09508391A (ja) | 1997-08-26 |
WO1995020600A1 (fr) | 1995-08-03 |
AU698738B2 (en) | 1998-11-05 |
JP3477713B2 (ja) | 2003-12-10 |
EP0741744B1 (fr) | 1999-08-11 |
US5688506A (en) | 1997-11-18 |
DE69511379D1 (en) | 1999-09-16 |
GR3031716T3 (en) | 2000-02-29 |
EP0741744A1 (fr) | 1996-11-13 |
DE69511379T2 (de) | 1999-11-25 |
AU1737195A (en) | 1995-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0741744T3 (da) | Immunogener mod gonadeotropinfrigørende hormon | |
DK0708656T3 (da) | Antigene LHRH peptidkonstruktioner og universelle syntetiske immunstimulatorer til vacciner | |
ATE116993T1 (de) | Saponin-hilfsmittel. | |
MX9101784A (es) | Formulaciones,metodos y dispositivos anticonceptivos transdermicos | |
TR199701252T1 (xx) | Bir saponin ve bir sterol i�eren a��lar. | |
IS5329A (is) | Flutningskerfi fyrir antígen þar sem monoglýseríðeða díglýseríð afleiður eru ónæmisglæðar | |
DK377084D0 (da) | Hormonpraeparat til behandling af menopausale forstyrrelser | |
EP0865293A4 (fr) | Blocage de la retro-regulation de lymphocytes t associee a la signalisation par ctla-4 | |
DK0914114T3 (da) | Fremgangsmåder til behandling af type I-hypersensitivitet under anvendelse af monophosphoryl-lipid A | |
ATE124265T1 (de) | Idiotypen-impfung gegen b-zell-lymphoma. | |
NZ331557A (en) | Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis | |
NO20005145L (no) | FremgangsmÕte for behandling av fertilitetsproblemer | |
EP0282343A3 (fr) | Méthode pour stimuler la réponse immunitaire à des antigènes spécifiques | |
ATE279198T1 (de) | Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung | |
AU4534893A (en) | Contraceptive vaccine | |
BG102083A (en) | Compositions and methods for the detection and treatment of aids | |
JPS5214238A (en) | Sheath heater terminal mouth closing | |
EP1555316A3 (fr) | Immunisation par bibliothèque d'antigènes | |
方剑乔 et al. | INHIBITORY EFFECT OF ELECTROACUPUNCTURE ON FEVER INDUCED BY LIPOPOLYSACCHARIDE, INTERLEUKIN-1βAND PROSTAGLANDIN E_2 IN RATS | |
MX9705082A (es) | Composiciones para el suministro de antigenos. | |
TH27045B (th) | วัคซีน |